The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab

Subjects

Subjects :

CD20
Cell Death
biology
business.industry
medicine.drug_class
Antineoplastic Agents
Dendritic Cells
Hematology
Antigens, CD20
medicine.disease
Monoclonal antibody
Lymphoma
Antibodies, Monoclonal, Murine-Derived
Antigen
Immunology
Monoclonal
medicine
biology.protein
Humans
Immunogenic cell death
Rituximab
Antibody
business
medicine.drug

Details

ISSN :

00071048

Volume :

162

Database :

OpenAIRE

Journal :

British Journal of Haematology

Accession number :

edsair.doi.dedup.....9746c5c23a1af4fb01c7c4166ddc1d0c

Full Text :

https://doi.org/10.1111/bjh.12427